Cargando…
High content drug screening for Fanconi anemia therapeutics
BACKGROUND: Fanconi anemia is a rare disease clinically characterized by malformations, bone marrow failure and an increased risk of solid tumors and hematologic malignancies. The only therapies available are hematopoietic stem cell transplantation for bone marrow failure or leukemia, and surgical r...
Autores principales: | Montanuy, Helena, Camps-Fajol, Cristina, Carreras-Puigvert, Jordi, Häggblad, Maria, Lundgren, Bo, Aza-Carmona, Miriam, Helleday, Thomas, Minguillón, Jordi, Surrallés, Jordi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325660/ https://www.ncbi.nlm.nih.gov/pubmed/32605631 http://dx.doi.org/10.1186/s13023-020-01437-1 |
Ejemplares similares
-
Epigenetic Alterations in Fanconi Anaemia: Role in Pathophysiology and Therapeutic Potential
por: Belo, Hélio, et al.
Publicado: (2015) -
Upregulation of NKG2D ligands impairs hematopoietic stem cell function in Fanconi anemia
por: Casado, José A., et al.
Publicado: (2022) -
Dysfunctional telomeres in primary cells from Fanconi anemia FANCD2 patients
por: Joksic, Ivana, et al.
Publicado: (2012) -
Mosaicism in Fanconi anemia: concise review and evaluation of published cases with focus on clinical course of blood count normalization
por: Nicoletti, Eileen, et al.
Publicado: (2020) -
FANCA Gene Mutations in North African Fanconi Anemia Patients
por: Ben Haj Ali, Abir, et al.
Publicado: (2021)